Roivant Sciences Ltd. — Director's Dealing 2025

Dec 30, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Roivant Sciences Ltd. (ROIV)
CIK: 0001635088
Period of Report: 2025-12-23

Reporting Person: Torti Frank (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-12-23	Common Shares	A	175380	$22.45	Acquired	13911927	Direct
2025-12-24	Common Shares	J	64891	$22.47	Disposed	13847036	Direct
2025-12-24	Common Shares	G	110489	—	Disposed	13736547	Direct

Footnotes

F1: Represents Common Shares received in exchange for shares of a subsidiary of the Issuer. The per Common Share price represents the closing price of the Issuer's Common Shares on the date of the exchange.

F2: The price reported in column 4 is a weighted average price. These Common Shares were sold in multiple transactions at prices ranging from $22.45 to $22.50, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range.

F3: Represents a sale of Common Shares only to cover estimated taxes due in connection with the exchange described in footnote 1.

F4: The Reporting Person donated 110,489 Common Shares to a donor advised fund, which will use the gifted Common Shares for charitable purposes.